Leadership

Dr. Dorothy Lennon’s clinical interests include: physician health, stigma reduction, MOUD and 12-step recovery.

Dr. Torres-Lockhart is board certified in addiction medicine and internal medicine and credentialed as an HIV specialist by the AAHIVM. She is founding director of the Addiction Consult Service at Montefiore’s Weiler Hospital and co-director of the Addiction Medicine rotation for medical trainees. She is focused on integrating addiction medicine into medical education and leads the development and implementation of health system interventions to improve substance use disorder (SUD) care in acute care settings and transitions of care to post-acute and ambulatory care settings.

Dr. Herman has a long-standing interest in the treatment of Co-occurring Psychiatric Disorders and Substance Use Disorders (Dual Diagnosis) including both psychotherapeutic and pharmacologic management.  In addition, I have a long-standing interest in the treatment of OUD, especially working with methadone patients.  In addition, oversees the Addiction Psychiatry Fellowship at Montefiore/Einstein and is passionate about education in the field. Additionally he is the former Founding President of NYSAM, current member of the Nominating Committee and member of the ASAM National Membership Council.

Dr. Aaron Fox is board certified in internal medicine and addiction medicine. His clinical care and research involves opioid use disorder treatment in primary care, syringe services programs, and criminal justice settings. Dr. Fox is the Director of the Bronx Transitions Clinic, which provides a medical home to people who were recently released from jail or prison, and he maintains an NIH-funded program of clinical research focused on buprenorphine treatment interventions.  

Norman Wetterau has been involved in addiction medicine since 1985 and helped start NYSAM as an active chapter. He is a family physician and provides addiction services in his primary care practice and through CASA Trinity in rural NY. He is clinical associate professor of family medicine, University of Rochester and heads up ASAM’s primary care interest group among other things. 

Dr. Selzer is Medical Director of the Committee for Physician Health (NY’s physician health program), Director of Northwell Health’s Physician Resource Network (Northwell’s EAP for medical students and physicians), and Public Policy Committee Chair for ASAM.  His interests in addiction medicine are substance use and substance use disorders in physicians, substance use and substance use disorder treatment public policy, and developing addiction medicine advocacy opportunities for students and physicians.  His goall is for ASAM to help our patients receive better care and to help those of us who work in addiction medicine to have better professional lives. 

Dr. Linda Wang is a general internist and addiction medicine specialist who cares for people who use drugs at the REACH Program at Mount Sinai, where she also directs the buprenorphine treatment program. She is the Medical Director for the Hepatitis C and Drug User Health Center of Excellence at the Institute for Advanced Medicine at Mount Sinai, part of the New York State Clinical Education Initiative. She is an active clinician educator who is interested in expanding access to substance use disorder treatment, stigma-free care for people who use drugs, and training current and future clinicians in drug user health.